XILTESS 15mg film-coated tablets EGIS
rivaroxaban Indicated for: prevention and treatment of thromboembolism
letter X · page 8
rivaroxaban Indicated for: prevention and treatment of thromboembolism
rivaroxaban Indicated for: prevention and treatment of thromboembolism
rivaroxaban Indicated for: prevention and treatment of thromboembolism
ranibizumab Indicated for: macular degeneration; diabetic macular edema
S01LA04 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
sertraline Indicated for: depression; anxiety disorders
N06AB06 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
rivaroxaban Indicated for: prevention and treatment of thromboembolism
rivaroxaban Indicated for: prevention and treatment of thromboembolism
rivaroxaban Indicated for: prevention and treatment of thromboembolism
montelukast Indicated for: asthma; allergic rhinitis
sertraline Indicated for: depression; anxiety disorders
N06AB06 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
montelukast Indicated for: asthma; allergic rhinitis
baloxavir marboxil Indicated for: influenza
J05AX25 Antiinfectives for systemic use | Direct acting antivirals | Other antivirals
baloxavir marboxil Indicated for: influenza
J05AX25 Antiinfectives for systemic use | Direct acting antivirals | Other antivirals
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases
omalizumab Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps
R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases